Skip to content

Day-night Rhythm in Muscle Metabolism of Prediabetics

Day-night Rhythm in Muscle Metabolism of Prediabetic Subjects

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03733743
Enrollment
12
Registered
2018-11-07
Start date
2018-07-09
Completion date
2019-03-29
Last updated
2019-08-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2, Insulin Resistance

Keywords

Circadian Rhythm

Brief summary

This study evaluates the existence of a day-night rhythm in skeletal muscle energy metabolism in prediabetic subjects. Subjects will stay at the research facility for 44 hours with a standardized living protocol during which several measurements of skeletal muscle and whole body energy metabolism will be performed.

Detailed description

Recent evidence from both observational and experimental studies indicates that disobedience of a normal day-night rhythm negatively influences metabolic and cardiovascular health, possibly leading to obesity and type 2 diabetes mellitus (T2DM). An important hallmark of obesity and T2DM is a decreased skeletal muscle mitochondrial function. Interestingly, recent research indicates that also skeletal muscle mitochondrial function is under the influence of a day-night rhythm. In this study, the presence of a day-night rhythm in skeletal muscle energy metabolism (in particular mitochondrial function) of overweight prediabetic participants will be investigated. During this study, subjects will stay at the research unit for 44 hours, with standardized meals and sleeping time. Five muscle biopsies (v. lateralis) and frequent blood draws will be taken. In addition, indirect calorimetry measurements will be performed.

Interventions

Subjects stay at the research facility for 44 hours and adhere to a standard sleeping, eating and activity protocol. During this protocol, multiple measurements will be performed including skeletal muscle biopsies (m. vastus lateralis), blood draws, indirect calorimetry and MRS measurements.

Sponsors

Maastricht University Medical Center
CollaboratorOTHER
Maastricht University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

Standardized living protocol

Eligibility

Sex/Gender
MALE
Age
40 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Caucasian * Healthy (as determined by dependent physician) * Overweight: BMI 25 - 35 kg/m2 * Prediabetic based on one or a combination of the following criteria: * Impaired Glucose Tolerance (IGT): plasma glucose values ≥ 7.8 mmol/l and ≤ 11.1 mmol/l 120 minutes after glucose drink consumption during OGTT in screening. * Impaired Fasting Glucose (IFG): Fasting plasma glucose ≥ 6.1 mmol/l and ≤ 6.9 mmol/l. * Insulin Resistance: glucose clearance rate ≤ 360ml/kg/min, as determined using the OGIS120 model. * HbA1c of 5.7-6.4%. * Regular sleeping time (normally 7 - 9h daily) * Stable dietary habits: no weight gain or loss \> 3kg in the last three months.

Exclusion criteria

* Use of anticoagulants * Previously diagnosed with type 2 diabetes * Current alcohol consumption \> 20 grams alcohol/day * Extreme early bird or extreme night person (score ≤ 30 or ≥ 70 on MEQ-SA questionnaire) * Heavily varying sleep-wake rhythm * Nightshift work during last 3 months * Travel across \> 1 time zone in the last 3 months * Significant food allergies/intolerance (seriously hampering study meals) * Using \> 400mg caffeine daily (more than 4 coffee or energy drink) * Smoking

Design outcomes

Primary

MeasureTime frameDescription
Day-night rhythm in skeletal muscle mitochondrial respirationmeasured on day two at 8:00, 13:00, 18:00, 23:00, 04:00O2-flux (pmol/mg/s) measured with high resolution respirometry

Secondary

MeasureTime frameDescription
Day-night rhythm in whole-body energy metabolism (glucose oxidation)measured on day two at 8:00, 13:00, 18:00, 23:00, 04:00glucose oxidation (g/min) measured by indirect calorimetry
Day-night rhythm in whole-body energy metabolism (fat oxidation)measured on day two at 8:00, 13:00, 18:00, 23:00, 04:00fat oxidation (g/min) measured by indirect calorimetry
Day-night rhythm in muscle protein levels of markers involved in molecular clock and mitochondrial metabolism.measured on day two at 8:00, 13:00, 18:00, 23:00, 04:00Quantify protein levels by Western blots
Day-night rhythm in muscle DNA of markers involved in molecular clock and mitochondrial metabolism.measured on day two at 8:00, 13:00, 18:00, 23:00, 04:00Quantify DNA by qPCR
Day-night rhythm in muscle DNA involved in molecular clock and mitochondrial metabolism.measured on day two at 8:00, 13:00, 18:00, 23:00, 04:00Quantify DNA by micro-array
Day-night rhythm in muscle mRNA markers involved in molecular clock and mitochondrial metabolism.measured on day two at 8:00, 13:00, 18:00, 23:00, 04:00Quantify mRNA levels by micro array
Day-night rhythm of markers of normal day-night rhythm (cortisol)measured on day two, every two hours for 24 hours beginning at 08:00Blood cortisol levels
Day-night rhythm in whole-body energy metabolism (energy expenditure)measured on day two at 8:00, 13:00, 18:00, 23:00, 04:00Energy expenditure (kJ/min) measured by indirect calorimetry
Day-night rhythm of in markers of normal day-night rhythm (melatonin)measured on day two, every two hours for 24 hours beginning at 08:00Blood melatonin levels.
Day-night rhythm in serum glucosemeasured on day two, every two hours for 24 hours beginning at 08:00Serum glucose levels determined from venous blood draws
Day-night rhythm in serum insulinmeasured on day two, every two hours for 24 hours beginning at 08:00Serum insulin levels determined from venous blood draws
Day-night rhythm in serum free fatty acids (FFA)measured on day two, every two hours for 24 hours beginning at 08:00Serum FFA levels determined from venous blood draws
Day-night rhythm in serum triglyceridesmeasured on day two, every two hours for 24 hours beginning at 08:00Serum triglyceride levels determined from venous blood draws
Day-night rhythm in serum cholesterolmeasured on day two, every two hours for 24 hours beginning at 08:00Serum cholesterol levels determined from venous blood draws
Change in energy status of the heart between morning and eveningMeasured on first study day 5:30 PM (duration 45 minutes), second study day 7:30 AM (duration 45 minutes)variation in phosphorus metabolites measured by Magnetic Resonance Imaging and - Spectroscopy (MRI/MRS)
Day-night rhythm of in markers of normal day-night rhythm (core body temperature)measured continuously for 24 hours on day twoCore body temperature measured by an ingested telemetric pill.

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026